Machine-Learning-Based Radiomics MRI Model for Survival Prediction of Recurrent Glioblastomas Treated with Bevacizumab

Anti-angiogenic therapy with bevacizumab is a widely used therapeutic option for recurrent glioblastoma (GBM). Nevertheless, the therapeutic response remains highly heterogeneous among GBM patients with discordant outcomes. Recent data have shown that radiomics, an advanced recent imaging analysis m...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diagnostics (Basel)
Autori principali: Ammari, Samy, Sallé de Chou, Raoul, Assi, Tarek, Touat, Mehdi, Chouzenoux, Emilie, Quillent, Arnaud, Limkin, Elaine, Dercle, Laurent, Hadchiti, Joya, Elhaik, Mickael, Moalla, Salma, Khettab, Mohamed, Balleyguier, Corinne, Lassau, Nathalie, Dumont, Sarah, Smolenschi, Cristina
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8305059/
https://ncbi.nlm.nih.gov/pubmed/34359346
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics11071263
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi